IRS Logo
Print - Click this link to Print this page

Qualifying Therapeutic Discovery Project Grants for the State of Indiana

The listings below represent the applicants that have been awarded a Qualifying Therapeutic Discovery Program Grant.

The project descriptions below were extracted from the applicant certification forms as submitted.

Indiana $ 10,293,530.56
Applicant Name Project Name Grants Awarded for 2009 Grants Awarded for 2010
Aarden Pharmaceuticals Inc Development of Novel Drugs Targeting Key Protein Tyrosine Phospatase Disease Targets $ 86,772.79 $ 157,706.45
Admiral Medical Supply, Inc Qualifying Therapeutic Discovery Project Credit   $ 180,750.00
AgeneBio Inc Development of Low Dose Levetiracteam Therapy for Amnestic Mild Cognitive Impairment $ 28,750.00 $ 50,750.00
AgeneBio Inc Development of GABAA a5 agonists for treatment of amnestic Mild Cognitive Impairment (aMCI); these compounds may also modify or slow progression to Alzheimer's Disease. $ 30,387.50 $ 206,500.00
Akina, Inc. Microfabrication $ 144,623.50  
ApeX Therapeutics, Inc Development of APE1 Inhibitors for Treatment of Cancers and Retinal Diseases $ 14,842.52 $ 164,063.04
Ash Access Technology, Inc Zuragen Catheter Lock Solution $ 244,479.25  
Ash Access Technology,Inc ZuraPrep Preoperative Skin Preparation $ 164,370.59 $ 64,472.88
BIOSCIENCE VACCINES INC The Development of Improved Vaccines for Human Use $ 44,692.50 $ 199,786.74
Chemigen, LLC CC100 Project ALS $ 92,371.50 $ 152,107.75
CS-Keys, Inc Definitive cancer diagnosis with a conserved biomarker of malignacy $ 244,479.24  
Dunigan Medical Inc Proton/Photon flexible dosimetry and organ displacement catheters $ 75,000.00 $ 65,000.00
Elona Biotechnologies Inc USP Insulin $ 244,479.25  
EndGenitor Technologies, Inc Neovascular Cell Therapeutic for Cardiovascular Disease $ 199,566.00 $ 44,913.25
Endocyte Inc EC20 $ 244,479.25  
Endocyte Inc PSMA $ 244,479.25  
Endocyte Inc EC0489 $ 244,479.25  
Endocyte Inc EC145 $ 244,479.25  
Endocyte, Inc EC0531 $ 185,000.50 $ 59,478.75
Endocyte, Inc Inflammation $ 244,479.25  
Focus Surgery inc Development of Laparoscopic Probe to treat of metastatic cancers {prostate pancreas, ect} $ 244,479.25  
General Bio Technology, LLC Therapeutic Angiogenesis by Universal Donor Endometrial Regenerative Cells $ 24,523.99 $ 70,145.27
General Bio Technology, LLC A Novel Approach to GMP Production of Tooth Derived Stem Cells $ 115,913.17 $ 128,566.07
General Bio Technology, LLC Automated Closed System for DMSO Removal from Peripheral Blood Stem Cells $ 244,479.24  
General BioTechnology, LLC A public umbilical cord blood bank to facilitate allogenic cord blood transplantation $ 85,639.72 $ 148,771.26
Glucago LLC Innovative Delivery Device For a Wide Rangeof Lyophilized Drugs $ 11,800.51 $ 232,678.74
GRest Inc Reversible Gastric Sleeve Implant for Substantial Weight Loss with Preserved Anatomy $ 110,178.50 $ 134,300.75
Horizon Biotechnologies, LLC AVN316   $ 244,479.25
IKOTECH LLC Magnetic Sorter Channels for Stem Cells. $ 70,242.45 $ 89,760.96
IVDiagnostics LLC IVD Onco Dx - CTC Platform $ 106,021.00 $ 138,458.24
Kylin Therapeutics Inc KT-105 a pRNA nanoparticle for cancer treatment $ 244,479.24  
Marcadia Biotech, Inc. GIP/GLP - 1 Dual Agonist for Treatment of Diabetes and Obesity $ 244,479.25  
Matrix Bio, Inc. Metabolite Profiling Technology $ 100,284.50 $ 84,000.00
Morris Innovative Inc. Femoral Introducer Sheath and Hemostasis Device $ 244,479.25  
NOX Technologies, Inc. Oral arNOX inhibitors for Atherogensis Prevention and Skin Health $ 93,954.50 $ 150,524.74
Park Funding, LLC d/b/a Semafore Pharmaceuticals SF1126-Dual mTOR-P13K Inhibition For Next Generation Cancer Treatment $ 244,479.25  
PDS BIOTECHNOLOGY CORPORATION DEVELOPMENT OF POTENT, SAFE AND COST EFFECTIVE THERAPEUTIC (CURATIVE) CANCER VACCINES $ 244,479.24  
Pericardial Access, Inc Rapid, Safe, Controlled Access to the Pericardial Space for Left Ventricle Lead Delivery $ 152,888.50 $ 91,590.75
Pharmacophotonics, Inc FAST GFR System $ 244,479.24  
Preclinomics, Inc Fatzo mouse, obese diabetic (type II) mouse model without leptin/leptin-receptor defects $ 64,308.00 $ 54,050.00
Preclinomics, Inc ZDSD rat, an obese diabetic (typeII) rat model without leptin/leptin-receptor defects $ 227,381.50 $ 17,097.74
ProCure Treatment Centers, Inc. Negative Pressure Breast Stabilization Device (BSD) $ 158,700.00 $ 85,779.24
Solstice Medical,LLC RFSuite System $ 244,479.25  
SonarMed, Inc SonarMed Airway Monitoring System (AMS) $ 244,479.25  
Symbios Holdings, Inc GOPump Rapid Recovery System $ 244,479.25  
SynTherix Inc Therapeutic Compounds for the treatment of Cancer $ 164,725.00 $ 79,754.25

 

Page Last Reviewed or Updated: 04-Jun-2014